They Just Don't Get...
Health Care: Drugs
AspenBio Pharma Inc. (APPY: NASDAQ)
$0.49 0.01 | 2.51%
06/04/12 - 10:18 AM ET
TheStreet Ratings Grade for APPY
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 0 | 0 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 3.00 | 3.00 | 3.00 | 3.00 |
Portfolios with APPY
- Portfolio NameUser Type
- UserSUPRATRADE-2709091838
- UserBrahmsian's Debt/Equity Por...
- UserBrahmsian's Financially Sou...
- Userdan vosika Portfolio 1
- Usergame on
- Userdreamerl3oi Portfolio 1
- Useremannn Portfolio 1
- UserKBEE Portfolio 1
- UserMoney and Suits Portfolio 1
- UserFly Me To The Moon Monster ...
Latest APPY Headlines from TheStreet
- Biotech Sector Weekly Rewind 11.13.10 | 07:11 am
- Vantage Drilling, First M&F: Volume Movers 07.20.10 | 07:07 am
- AspenBio Finds Fault Afar for Failure 07.20.10 | 06:07 am
- Biotech Stock Mailbag: Spectrum Pharma 06.18.10 | 07:06 am
- Hellenic Telecom, AspenBio Pharma: Midday Volume Plays 06.07.10 | 12:06 pm
- Stock Offerings: Navios Maritime 04.30.10 | 11:04 am
- Biotech Stock Mailbag: AspenBio 04.30.10 | 06:04 am
- ClickSoftware, AspenBio: Early Volume Plays 12.29.09 | 07:12 am
- AspenBio Pharma Prices Public Offering 10.07.09 | 08:10 am
- Biotech News Roundup: Aspen, AMAG, Vertex 08.17.09 | 12:08 pm
Press Releases for APPY
- AspenBio Appoints Diagnostics Industry Veteran Don Hurd As Senior Vice President And Chief Commercial Officer - Business Wire 05.24.12 | 09:05 am
- AspenBio Pharma’s Clinical Study Suggests One-Third Of CT Scans Used To Assess Pediatric And Adolescent Patients At Low Risk For Acute Appendicitis Could Potentially Be Avoided - Business Wire 04.18.12 | 09:04 am
- Results Of 503-Patient Clinical Study Of AspenBio Pharma’s AppyScore™ Blood Test Show 97% Negative Predictive Value For Absence Of Acute Appendicitis In Children And Adolescents Presenting With Abdominal Pain - Business Wire 03.16.12 | 02:03 pm
- Study Demonstrates AspenBio Pharma’s AppyScore Multi-Marker Blood Test Highly Predictive For Absence Of Acute Appendicitis In Children With Abdominal Pain - Business Wire 02.28.12 | 09:02 am
- Rigrodsky & Long, P.A. Announces Class Action Lawsuit Against AspenBio Pharma, Inc. - Business Wire 10.07.10 | 04:10 pm
- The Law Office Of Robbins Umeda LLP Announces The Filing Of A Class Action Suit Against AspenBio Pharma, Inc. - Business Wire 10.07.10 | 04:10 pm
- Investor Notice: The Rosen Law Firm Announces Investigation Of Shareholder Securities Claims Against AspenBio Pharma, Inc. --- APPY - Business Wire 09.03.10 | 08:09 pm
Partner Headlines for APPY
- Morning Market Losers - Benzinga 12.19.11 | 09:12 am
- AspenBio Pharma Reports AppyScore(TM) ELISA-Based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-Based Test - Benzinga 07.19.10 | 04:07 pm
- AspenBio Pharma Shares Plummet on Drug Application Delay - Fox Business 06.07.10 | 04:06 pm
- 4 Small Cap Biotechs To Keep an Eye On - Seeking Alpha 05.26.10 | 04:05 pm
- Thursday Outlook: What, Me Worry? - Seeking Alpha 05.13.10 | 10:05 am
- Biotech CROs Take Center Stage in Recent Deals - Seeking Alpha 05.02.10 | 05:05 am
- Takeover Speculation Swarms at AspenBio Pharma - SeekingAlpha.com 04.26.10 | 03:04 am
- Preview of AspenBio's Potentially Blockbuster Clinical Trials - SeekingAlpha.com 04.25.10 | 08:04 am
- Friday Options Recap - SeekingAlpha.com 04.23.10 | 03:04 pm
- Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps? - SeekingAlpha.com 04.22.10 | 04:04 am
